18th Sep 2020 21:16
Fusion Antibodies PLC - pharmaceutical company based in Belfast - Says proof-of-concept on Mammalian Antibody Library Discovery Platform, Covid-19 related research. Fusion Antibodies says "progress" being made on design of SARS-CoV-2 proteins as it looks to develop antigens to fight against virus. Stock more than doubled on Friday.
Current stock price: 222.67 pence
Year-to-date change: up sharply from 78.50p
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Fusion Antibodies